Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing ’s Sarcoma

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing’s Sarcoma Molecular Therapy 24, 1412 (August 2016). doi:10.1038/mt.2016.93 Authors: Donald D. Rao, Christopher Jay, Zhaohui Wang, Xiuquan Luo, Padmasini Kumar, Hilary Eysenbach, Maurizio Ghisoli, Neil Senzer & John Nemunaitis

http://feeds.nature.com/~r/mt/rss/current/~3/IL91RoXhkdw/mt.2016.93

Source: Molecular Therapy - August 30, 2016 Category: Genetics & Stem Cells Authors: Donald D. Rao Christopher Jay Zhaohui Wang Xiuquan Luo Padmasini Kumar Hilary Eysenbach Maurizio Ghisoli Neil Senzer John Nemunaitis Source Type: research

More News: Bone Cancers | Genetics | Sarcomas